Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
Sunnia T. Chen(The Ohio State University Wexner Medical Center), Daniel Addison(The Ohio State University Wexner Medical Center), Lindsay Rosen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Tracy Wiczer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jennifer A. Woyach(The Ohio State University), John Alan Gambril(The Ohio State University Wexner Medical Center), Patrick Ruz(The Ohio State University Wexner Medical Center), Kerry A. Rogers(The Ohio State University), Sujay Kalathoor(The Ohio State University Wexner Medical Center), Seema A. Bhat(The Ohio State University), Michael R. Grever(Johns Hopkins University), Leylah Azali(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Farrukh T. Awan(The Ohio State University), Adam S. Kittai(The Ohio State University Wexner Medical Center), Qiuhong Zhao(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), John C. Byrd(The Ohio State University), Marilly Palettas(The Ohio State University), Onaopepo Kola‐Kehinde(The Ohio State University Wexner Medical Center)
Cited by 36
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890